Articoli con mandati relativi all'accesso pubblico - Hans LassmannUlteriori informazioni
TotaleFWFNIHDFGINSERMEuropean CommissionCIHRMRCOTKAParkinson's UKBMBFSNSFDoDSwedish Research CouncilNIHRMultiple Sclerosis Society, UKFRQSNSERCDOEHHMIAHANHMRCVillum FoundationAlzheimers's UKMotor Neurone Disease Association, UKWellcomeANRMultiple Sclerosis Society of CanadaGoverno ItalianoNSFACLDFFCSONational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKMSFHRGovernment of SpainNKFIHFSP
Non disponibili pubblicamente: 15
Pathology and disease mechanisms in different stages of multiple sclerosis
H Lassmann
Journal of the neurological sciences 333 (1-2), 1-4, 2013
Mandati: Austrian Science Fund
Long-term evolution of multiple sclerosis iron rim lesions in 7 T MRI
A Dal-Bianco, G Grabner, C Kronnerwetter, M Weber, B Kornek, ...
Brain 144 (3), 833-847, 2021
Mandati: Austrian Science Fund, Multiple Sclerosis Society, UK
The influence of brain iron and myelin on magnetic susceptibility and effective transverse relaxation-A biochemical and histological validation study
S Hametner, V Endmayr, A Deistung, P Palmrich, M Prihoda, ...
Neuroimage 179, 117-133, 2018
Mandati: German Research Foundation
In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection
G Martin-Blondel, J Bauer, V Cuvinciuc, E Uro-Coste, A Debard, P Massip, ...
Neurology 81 (11), 964-970, 2013
Mandati: National Institute of Health and Medical Research, France
The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation
EM Nicolussi, S Huck, H Lassmann, M Bradl
Neurobiology of disease 35 (1), 24-31, 2009
Mandati: Austrian Science Fund
Therapeutic use of CCR5 antagonists is supported by strong expression of CCR5 on CD8+ T cells in progressive multifocal leukoencephalopathy-associated …
G Martin-Blondel, J Bauer, E Uro-Coste, D Biotti, D Averseng-Peaureaux, ...
Acta neuropathologica 129, 463-465, 2015
Mandati: National Institute of Health and Medical Research, France
Cutting edge: neuronal recognition by CD8 T cells elicits central diabetes insipidus
T Scheikl, B Pignolet, C Dalard, S Desbois, D Raison, M Yamazaki, ...
The Journal of Immunology 188 (10), 4731-4735, 2012
Mandati: National Institute of Health and Medical Research, France
Pathogenic autoantibodies in multiple sclerosis—from a simple idea to a complex concept
R Höftberger, H Lassmann, T Berger, M Reindl
Nature Reviews Neurology 18 (11), 681-688, 2022
Mandati: Austrian Science Fund
Transcription factor Gfi1 restricts B cell-mediated autoimmunity
C Rathinam, H Lassmann, M Mengel, C Klein
The Journal of Immunology 181 (9), 6222-6229, 2008
Mandati: German Research Foundation
KIR4. 1: another misleading expectation in multiple sclerosis?
M Filippi, MA Rocca, H Lassmann
The Lancet Neurology 13 (8), 753-755, 2014
Mandati: Governo Italiano
Spinal cord pathology in multiple sclerosis
H Lassmann
The Lancet Neurology 14 (4), 348-349, 2015
Mandati: National Health and Medical Research Council, Australia
Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system
R Grundtner, K Dornmair, R Dahm, A Flügel, N Kawakami, M Zeitelhofer, ...
Neurobiology of disease 28 (3), 261-275, 2007
Mandati: German Research Foundation
A novel concept of treatment in MS: targeting both oligodendrocyte death and inflammatory processes by inhibiting poly (adp-ribose) polymerase
Z Illes, H Lassmann, F Gallyas Jr
Multiple Sclerosis Immunology: A Foundation for Current and Future …, 2013
Mandati: Hungarian Scientific Research Fund
The susceptibility to experimental autoimmune encephalomyelitis is not related to dysferlin-deficiency
S Hochmeister, RE Bittner, H Höger, H Lassmann, M Bradl
Autoimmunity 42 (3), 235-241, 2009
Mandati: Austrian Science Fund
The influence of MOGAD on diagnosis of multiple sclerosis using MRI
R Geraldes, G Arrambide, B Banwell, À Rovira, R Cortese, H Lassmann, ...
Nature Reviews Neurology, 1-16, 2024
Mandati: National Institute for Health Research, UK
Disponibili pubblicamente: 149
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases
S Krasemann, C Madore, R Cialic, C Baufeld, N Calcagno, R El Fatimy, ...
Immunity 47 (3), 566-581. e9, 2017
Mandati: US Department of Defense, US National Institutes of Health, Austrian Science …
Pathological mechanisms in progressive multiple sclerosis
DH Mahad, BD Trapp, H Lassmann
The Lancet Neurology 14 (2), 183-193, 2015
Mandati: US National Institutes of Health, Austrian Science Fund
Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research
R Gold, C Linington, H Lassmann
Brain 129 (8), 1953-1971, 2006
Mandati: German Research Foundation
Inflammatory cortical demyelination in early multiple sclerosis
CF Lucchinetti, BFG Popescu, RF Bunyan, NM Moll, SF Roemer, ...
New England Journal of Medicine 365 (23), 2188-2197, 2011
Mandati: US National Institutes of Health
Progressive multiple sclerosis: pathology and pathogenesis
H Lassmann, J Van Horssen, D Mahad
Nature Reviews Neurology 8 (11), 647-656, 2012
Mandati: Austrian Science Fund
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software